Skip to main content

Bristol Myers Squibb to Take Part in Bernstein’s 37th Annual Strategic Decisions Conference

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in a fireside chat at Bernstein’s 37th Annual Strategic Decisions Virtual Conference, which will be webcast on Wednesday, June 2, 2021. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer, will answer questions about the company at 10 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.



Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.